Page 333 - ATP-P 11th Ed

• Pain Management Protocol
• K9 Evaluation and Treatment Protocol
• K9 Trauma Management Protocol
• K9 RDX (C-4) Ingestion Protocol

®
Moxifloxacin (Avelox )
Aviation personnel are grounded for the initial 24hr of antibiotic therapy and until
the medical condition no longer interferes with safely performing aviation duties and the
patient is free of side-effects.
th
Description: 4 generation quinolone
• Broad spectrum antibiotic with broad anaerobic coverage for PO/IV administration.
Inhibits DNA preventing cellular replication and division
Indications:
• Community-acquired pneumonia (CAP), including CAP caused by multidrug-resistant
Streptococcus pneumoniae
• Complicated skin and skin structure infections, including diabetic foot infections
• Complicated intra-abdominal infections, including polymicrobial infections such as SECTION 3
abscesses
Dose: 400mg/day PO/IV
• IV infusion should be over 60min.
• Avoid use with antacids.
• Decrease dose in renal impairment.
• Avoid using with antiarrhythmics – may cause prolonged QT interval.
K9 Dose: 400mg orally daily
Contraindications:
• Hypersensitivity to fluroquinolones
• Patients <18 years old
• Pregnancy and lactation
• Uncorrected hypokalemia
Pregnancy Category C
Side-effects:
• Headache
• Nausea
• Diarrhea
• Photosensitivity
• Insomnia
• Vertigo
Adverse reactions:
• Tendon rupture

ATP-P Handbook 11th Edition 323